Effect of zinc supplementation on growth in West African children: a randomized double-blind placebo-controlled trial in rural Burkina Faso

Int J Epidemiol. 2003 Dec;32(6):1098-102. doi: 10.1093/ije/dyg190.

Abstract

Objective: To analyse the effects of zinc supplementation on growth parameters in a representative sample of young children in rural Burkina Faso. Design Randomized, double-blind, placebo-controlled efficacy trial. Setting Eighteen villages in rural northwestern Burkina Faso. Subjects In all, 709 children aged 6-31 months were enrolled; 685 completed the trial. Intervention Supplementation with zinc (12.5 mg zinc sulphate) or placebo daily for 6 days a week for 6 months. Outcomes Weight, length/height, mid-arm circumference, and serum zinc.

Results: In a representative subsample of study children, 72% were zinc-deficient at baseline. After supplementation, serum zinc increased in zinc-supplemented but not in control children of the subsample. No significant differences between groups were observed during follow-up regarding length/height, weight, mid-arm circumference, and z scores for height-for-age, weight-for-age, and weight-for-height.

Conclusions: We conclude that zinc supplementation does not have an effect of public health importance on growth in West African populations of young children with a high prevalence of malnutrition. Multinutrient interventions are likely to be more effective.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anthropometry
  • Body Height / drug effects
  • Body Weight / drug effects
  • Burkina Faso
  • Child, Preschool
  • Cross-Sectional Studies
  • Developing Countries
  • Dietary Supplements*
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Growth / drug effects*
  • Humans
  • Infant
  • Male
  • Malnutrition / physiopathology*
  • Rural Health
  • Zinc / blood
  • Zinc / deficiency
  • Zinc Sulfate / therapeutic use*

Substances

  • Zinc Sulfate
  • Zinc